×

Spasticity treatment with onabotulinumtoxin A: datafrom a prospective German real-life patient registry: Schramm A et al.

 

J Neural Transm DOI 10.1007/s00702-013-1145-3
 
Axel Schramm*
 Jean-Pierre Ndayisaba
Matthias auf dem Brinke
Martin Hecht
Christoph Herrmann
Martin Huber
Elmar Lobsien
Sabine Mehnert
Iris Reuter
Andrea Stenner
Christian van der Ven
Martin Winterholler
Andreas Kupsch
Joerg Wissel

 

Autoren-Details:
A. Schramm (*) Department of Neurology, University of Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany e-mail: axel.schramm@uk-erlangen.de
J.-P. Ndayisaba Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
M. auf dem Brinke Department of Neurology, Asklepios Klinik Fuerstenhof, Bad Wildungen, Germany
M. Hecht Department of Neurology, Bezirkskrankenhaus Kaufbeuren, Kaufbeuren, Germany
C. Herrmann Department of Neurological Rehabilitation, Asklepios Kliniken Schildautal, Seesen, Germany
M. Huber Department of Neurological Rehabilitation, Therapiezentrum Burgau, Burgau, Germany
E. Lobsien Department of Neurology, Universitaetsmedizin Berlin, Charite´,Campus Virchow, Berlin, Germany
S. Mehnert I. Reuter Department of Neurology, University of Gießen, Gießen, Germany
A. Stenner Department of Movement Disorders, Paracelsus Kliniken, Zwickau, Germany
C. van der Ven Neurologisches Rehazentrum Godeshoehe, Bonn, Germany